Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:(%22Biodisponibilit%C3%A9%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 13678

  • Page / 548
Export

Selection :

  • and

Integrin αvβ6 is an RGD-dependent receptor for coxsackievirus A9WILLIAMS, Cigdem H; KAJANDER, Tommi; HYYPIÄ, Timo et al.Journal of virology. 2004, Vol 78, Num 13, pp 6967-6973, issn 0022-538X, 7 p.Article

Internalization of Coxsackievirus A9 Is Mediated by β2-Microglobulin, Dynamin, and Arf6 but Not by Caveolin-1 or ClathrinHEIKKILÄ, Outi; SUSI, Petri; TEVALUOTO, Tuire et al.Journal of virology. 2010, Vol 84, Num 7, pp 3666-3681, issn 0022-538X, 16 p.Article

Preliminary crystallographic analysis of coxsackievirus A9SMYTH, M; HALL, J; FRY, E et al.Journal of molecular biology. 1993, Vol 230, Num 2, pp 667-669, issn 0022-2836Article

Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9HEIKKILÄ, Outi; SUSI, Petri; STANWAY, Glyn et al.Journal of general virology. 2009, Vol 90, pp 197-204, issn 0022-1317, 8 p., 1Article

Factors affecting virus plaque confirmation proceduresDAHLING, D. R; SULLIVAN, G; FREYBERG, R. W et al.Journal of virological methods. 1989, Vol 24, Num 1-2, pp 111-122, issn 0166-0934Article

Efficient RGD-independent entry process of coxsackievirus A9ROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Archives of virology. 1996, Vol 141, Num 10, pp 1909-1919, issn 0304-8608Article

An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9AL-HELLO, Haider; PAANANEN, Anja; ESKELINEN, Mervi et al.Journal of general virology. 2008, Vol 89, pp 1949-1959, issn 0022-1317, 11 p., 8Article

A CASE OF COXSACKIE A9 VIRUS INFECTION WITH ORCHITISWILLEMS WR; HORNIG C; BAUER H et al.1978; J. MED. VIROL.; USA; DA. 1978; VOL. 3; NO 2; PP. 137-140; BIBL. 8 REF.Article

A combined method for rescue of modified enteroviruses by mutagenic primers, long PCR and T7 RNA polymerase-driven in vivo transcriptionHEIKKILÄ, Outi; KAINULAINEN, Markus; SUSI, Petri et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 129-133, issn 0166-0934, 5 p.Article

FREISETZUNG ZELLULAERER ENZYME WAEHREND DER VERMEHRUNG VON COXSACKIEVIRUS A9 IN FL-ZELLEN. II.ABHAENGIGKEIT DER ENZYMFREISETZUNG VON ZELLDICHTE, VIRUSKONZENTRATION, PH-WERT UND SERUMGEHALT DES INKUBATIONSMEDIUMS = LIBERATION DE L'ENZYME CELLULAIRE AU COURS DE LA MULTIPLICATION DU COXSACKIEVIRUS A9 EN CELLULES FL. II.INFLUENCE DU NOMBRE DE CELLULES, DE LA CONCENTRATION DE VIRUS, DU PH ET DE LA TENEUR EN SERUM DU MILIEU DE CULTURE SUR CETTE LIBERATIONKLOCKING R; SCHWEIZER H; SPROSSIG M et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 3-4; PP. 353-359; ABS. ANGL.; BIBL. 10REF.Article

The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK StudyOSTOJIC, Miodrag C; PERISIC, Zoran; SAGIC, Dragan et al.European journal of clinical pharmacology. 2011, Vol 67, Num 4, pp 389-398, issn 0031-6970, 10 p.Article

A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virionsROIVAINEN, Merja; ALAKULPPI, Noora; YLIPAASTO, Petri et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 108-116, issn 0166-0934, 9 p.Article

Photoinactivation of three viruses by rose bengalLEWIS, A. L; WELLINGS, F. M; MARTIN, D. F et al.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 2, pp 127-137, issn 0360-1226Article

STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. I. PLAQUE-FORMING ABILITY OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES.MATSUMOTO M; NAKANO M; NISHIKAWA F et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 67-76; BIBL. 15 REF.Article

The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significantKI HA CHANG; DAY, C; WALKER, J et al.Journal of general virology. 1992, Vol 73, pp 621-626, issn 0022-1317, 3Article

A novel one-step oxidation of terminal epoxides to allylic aldehydesWILLIS, C. L.Tetrahedron letters. 1987, Vol 28, Num 19, pp 2175-2178, issn 0040-4039Article

COXSACKIEVIRUS AGGREGATES IN MUSCLE CELLS OF A POLYMYOSITIS PATIENT.GYORKEY F; CABRAL GA; GYORKEY PK et al.1978; INTERVIROLOGY; SWITZ.; DA. 1978; VOL. 10; NO 2; PP. 69-77; BIBL. 1 P. 1/2Article

STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. II. MODE OF GROWTH OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES AND THE EFFECT OF SULFATES POLYSACCHARIDE ON PLAQUE FORMATION.MATSUMOTO M; NAKANO M; TAGAYA I et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 77-90; BIBL. 11 REF.Article

GIBBERELLIN A9 GLUCOSYL ESTER IN NEEDLES OF PICEA SITCHENSIS.LORENZI R; HORGAN R; HEALD JK et al.1976; PHYTOCHEMISTRY; G.B.; DA. 1976; VOL. 15; NO 5; PP. 789-790; BIBL. 5 REF.Article

The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classificationKI HA CHANG; AUVINEN, P; HYYPIA, T et al.Journal of general virology. 1989, Vol 70, Num 12, pp 3269-3280, issn 0022-1317Article

Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometryCLAVIJO, Claudia; STROM, Tobin; MOLL, Vanessa et al.Journal of chromatography. B. 2009, Vol 877, Num 29, pp 3506-3514, issn 1570-0232, 9 p.Article

CONSTRUCTION OF VIABLE MOUSE-HUMAN HYBRID CELLS BY NUCLEAR TRANSPLANTATIONHIGHTOWER MJ; LUCAS JJ.1980; J. CELL. PHYSIOL.; ISSN 0021-9541; USA; DA. 1980; VOL. 105; NO 1; PP. 93-103; BIBL. 26 REF.Article

Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug-Eluting Stent SystemsCLAESSEN, Bimmer E; HENRIQUES, Jose P. S; DANGAS, George D et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, pp 4012-4024, issn 1381-6128, 13 p.Article

Mechanisms of coxsackievirus-induced damage to human pancreatic β-cellsROIVAINEN, M; RASILAINEN, S; YLIPAASTO, P et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 1, pp 432-440, issn 0021-972XArticle

Entry of coxsackievirus A9 into host cells : specific interactions with αvβ3 integrin, the vitronectin receptorROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Virology (New York, NY). 1994, Vol 203, Num 2, pp 357-365, issn 0042-6822Article

  • Page / 548